Taguchi Akihiko, Matsuyama Tomohiro, Moriwaki Hiroshi, Hayashi Takuya, Hayashida Kohei, Nagatsuka Kazuyuki, Todo Kenichi, Mori Katsushi, Stern David M, Soma Toshihiro, Naritomi Hiroaki
Department of Cerebrovascular Disease, National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565 Japan.
Circulation. 2004 Jun 22;109(24):2972-5. doi: 10.1161/01.CIR.0000133311.25587.DE. Epub 2004 Jun 7.
Increasing evidence points to a role for circulating endothelial progenitor cells, including populations of CD34- and CD133-positive cells present in peripheral blood, in maintenance of the vasculature and neovascularization. Immature populations, including CD34-positive cells, have been shown to contribute to vascular homeostasis, not only as a pool of endothelial progenitor cells but also as a source of growth/angiogenesis factors at ischemic loci. We hypothesized that diminished numbers of circulating immature cells might impair such physiological and reparative processes, potentially contributing to cerebrovascular dysfunction.
The level of circulating immature cells, CD34-, CD133-, CD117-, and CD135-positive cells, in patients with a history of atherothrombotic cerebral ischemic events was analyzed to assess possible correlations with the degree of carotid atherosclerosis and number of cerebral infarctions. There was a strong inverse correlation between numbers of circulating CD34- and CD133-positive cells and cerebral infarction. In contrast, there was no correlation between the degree of atherosclerosis and populations of circulating immature cells. Analysis of patients with cerebral artery occlusion revealed a significant positive correlation between circulating CD34- and CD133-positive cells and regional blood flow in areas of chronic hypoperfusion.
These results suggest a possible contribution of circulating CD34- and CD133-positive cells in maintenance of the cerebral circulation in settings of ischemic stress. Our data demonstrate the utility of a simple and precise method to quantify circulating CD34-positive cells, the latter providing a marker of cerebrovascular function.
越来越多的证据表明,循环内皮祖细胞,包括外周血中存在的CD34阳性和CD133阳性细胞群体,在血管维持和新生血管形成中发挥作用。包括CD34阳性细胞在内的未成熟细胞群体,不仅作为内皮祖细胞池,而且作为缺血部位生长/血管生成因子的来源,已被证明有助于血管稳态。我们推测循环中未成熟细胞数量减少可能会损害这种生理和修复过程,从而可能导致脑血管功能障碍。
分析有动脉粥样硬化性脑缺血事件病史患者循环未成熟细胞(CD34、CD133、CD117和CD135阳性细胞)的水平,以评估其与颈动脉粥样硬化程度和脑梗死数量之间的可能相关性。循环CD34阳性和CD133阳性细胞数量与脑梗死之间存在强烈的负相关。相反,动脉粥样硬化程度与循环未成熟细胞群体之间没有相关性。对脑动脉闭塞患者的分析显示,循环CD34阳性和CD133阳性细胞与慢性低灌注区域的局部血流之间存在显著正相关。
这些结果表明,在缺血应激情况下,循环CD34阳性和CD133阳性细胞可能有助于维持脑循环。我们的数据证明了一种简单精确的方法可用于量化循环CD34阳性细胞,后者可作为脑血管功能的标志物。